# Nuclide record fludeoxyglucose-f18 (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/fludeoxyglucose-f18/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "fludeoxyglucose-f18" ;
  schema:name "Fludeoxyglucose F-18 (FDG)"@en ;
  schema:description "The radioactive sugar used in almost every cancer PET scan, approved in the 1990s and made fresh each day by regional cyclotrons."@en ;
  schema:url <https://nuclide.cc/drugs/fludeoxyglucose-f18/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Fludeoxyglucose_(18F)> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fludeoxyglucose%20F%2018> ;
  nuclide:status "approved" ;
  nuclide:tag "test" ;
  nuclide:modality "PET imaging agent (glucose analogue)" ;
  schema:alternateName "FDG (multiple manufacturers)" ;
  nuclide:approval "US 1994: First FDG NDA (neurology and cardiology indications)", "US 2000: Oncology: assessment of abnormal glucose metabolism to assist in evaluating malignancy" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:indications <https://nuclide.cc/indications/nsclc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/fdg-pet/>, <https://nuclide.cc/technologies/pet-ct/>, <https://nuclide.cc/technologies/pet/> ;
  nuclide:companies <https://nuclide.cc/companies/petnet-solutions/>, <https://nuclide.cc/companies/cardinal-health/>, <https://nuclide.cc/companies/sofie-biosciences/> ;
  nuclide:terms <https://nuclide.cc/terms/suv/> .